Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

PS: The quotes after 2017-05-10 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Bristol-Myers Squ Static Chart

Rise of
+0.56 (+0.90%) Bristol-Myers Squ - [Ticker: BMY]Chart Bristol-Myers Squ  News Bristol-Myers Squ  Download Historical Prices for Metastock Bristol-Myers Squ and Others  Technical Analysis Bristol-Myers Squ  
Last Trade62.22Last Trade Time2017-11-01 - 19:35:00
Variation+0.56 (+0.90%)Open61.86
Volume3,541,547Average Volume (3m)0
YieldBid / Ask62.21 x 900 - 62.22 x 1,400
Former Close61.6652 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Bristol-Myers Squ [BMY]:   (ordered by relevance)
  1. What?s Happening With Bristol Myers Squibb Stock?  Forbes
  2. Bristol Myers Squibb Shares Are Still Undervalued (NYSE:BMY)  Seeking Alpha
  3. What Does This Regulatory News Mean for Bristol Myers Squibb's Shareholders?  Motley Fool
  4. Bristol Myers Squibb to Present at J.P. Morgan's 40th Annual Healthcare Conference  Business Wire
  5. Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know  Entrepreneur
What's Behind Bristol Myers Squibb's Latest Partnership?  The Motley Fool Bristol-Myers Targeted by Top Democrat on Offshore Tax Deal  Bloomberg Bristol Myers Squibb (BMY) Stock Moves -0.26%: What You Should Know Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know  Yahoo Finance Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities  Business Wire Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year  Nasdaq Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company?  Forbes Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know Bristol-Myers Squibb Company's (BMY) CEO Giovanni Caforio Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)  Seeking Alpha Bristol Myers Squibb (BMY) Crossed Above the 20-Day Moving Average: What That Means for Investors  Nasdaq Evotec expands neuroscience collaboration with Bristol Myers Squibb to include new targeted protein degradation approach  Evotec Bristol Myers Squibb Breaks Above 200-Day Moving Average - Bullish for BMY  Nasdaq Claybrook Capital, LLC Buys ProShares Ultra S&P500, Altria Group Inc, Bristol-Myers Squibb ...  Yahoo Finance Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers  FiercePharma Century Therapeutics (IPSC) and Bristol Myers Squibb (BMY) Announce Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies Eli Lilly, Bristol Myers in Cowen's list of big pharma with notable catalysts in Q1 2022  Seeking Alpha Competition intensifies in BCMA space with new approval for BMS  The Pharma Letter The Zacks Analyst Blog Highlights: Salesforce, Intuit, Bristol-Myers Squibb, QUALCOMM and Lockheed Martin  Yahoo Finance Evogene's Biomica Announces Clearance For First-In-Human Phase I Study Of BMC-128 In Combination With Bristol Myers Squibb's Anti-PD-1 Opdivo  Benzinga Hikari Power Ltd Buys Alphabet Inc, Vanguard Health Care ETF, Bristol-Myers Squibb Co, Sells ...  Yahoo Finance Bristol Myers Squibb - BMY - Stock Price & News  Motley Fool S&P 500 Movers: TTWO, BMY  Nasdaq Bristol Myers Squibb Announces Earnings Call Time Change; Third Quarter 2021 Earnings Call to Occur on October 27, 2021 at 10 a.m. (Eastern Time)  Business Wire Looking Into Bristol-myers Squibb Company's Recent Short Interest - Benzinga  Benzinga 14 Stocks in the Healthcare Sector - FAST Graphs - Commentaries  Advisor Perspectives Bristol Myers Squibb to Report Results for Fourth Quarter 2021 on February 4, 2022  Business Wire Here's Why Bristol Myers Squibb Stock Is Heating Up Today  The Motley Fool Should You Buy Bristol Myers Squibb Stock At $63?  Forbes 3 Big FDA Approvals to Watch For in Q1 2022  The Motley Fool Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials  Forbes Bristol Myers Launching Nine New Drugs After Bulking Up Pipeline  Bloomberg Bristol-Myers Squibb: Underperformance Is Temporary  Seeking Alpha IVE, PM, MDT, BMY: Large Inflows Detected at ETF  Nasdaq Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?  Motley Fool Bristol Myers Squibb Announces Dividend  Business Wire Why Metaverse Cryptos Axie Infinity, Decentraland, and Enjin Coin Plunged 20%+ Today  Nasdaq U.S. FTC okays changes to Bristol Meyers Squibb divestiture agreement  Reuters Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week  Motley Fool Bristol Myers Squibb Announces New PDUFA Date for Mavacamten  Business Wire Bristol-Myers Squibb (BMY) Q1 2021 Earnings Call Transcript  Motley Fool Bristol Myers' (BMY) Cardiovascular Drug Review Extended by FDA Bristol Myers, Immatics to Collaborate on IMA401 >BMY IMTX  MarketWatch Bristol Myers Squibb Awards ?Golden Tickets? to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabs  Business Wire 4 Perfect Dividend Stocks to Buy if There's a Stock Market Crash  Nasdaq Bristol-Myers Squibb (NYSE:BMY) Has Announced That It Will Be Increasing Its Dividend To US$0.54  Simply Wall St Bristol Myers Squibb: An Undervalued Dividend Stock With Growth Potential  Seeking Alpha Nektar And Bristol Myers Squibb Expecting Bempeg Approval  Seeking Alpha Fitch Affirms Bristol-Myers Squibb's IDR at 'A-'; Withdraws Ratings; Outlook Revised to Stable  Fitch Ratings Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland  Business Wire Bristol Myers Squibb Provides Update on Phase 2 Study of Deucravacitinib in Patients With Moderate to Severe Ulcerative Colitis  Business Wire 2 Best Warren Buffett Dividend Stocks to Buy Now  Motley Fool Bristol Myers Squibb Has Unique Cash Flow Strength  Seeking Alpha Bristol Myers Squibb's Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency  Business Wire Bristol Myers Squibb to Take Part in Morgan Stanley 19th Annual Global Healthcare Conference  Business Wire BRISTOL MYERS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY  Yahoo Finance Bristol Myers to pay up to $1.56 bln to develop, sell Agenus's cancer therapy (May 18)  Reuters Bristol-Myers Is Said to Have Weighed Offer for Acceleron  Bloomberg Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum - Benzinga  Benzinga 3 Reasons To Invest Like Buffett And Buy Bristol Myers  Seeking Alpha Global Sexually Transmitted Diseases (STDs) Drug Market 2021-2029 Trend Analysis and Top Companies: Pfizer INC, Hoffmann La Roche, Bayer Healthcare, Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb Co ? Discovery Sports Media  Discovery Sports Media BRISTOL MYERS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Comp  Yahoo Finance Bristol Myers Squibb to Present Data Across Robust Cardiovascular Portfolio at American Heart Association Scientific Sessions 2021  Yahoo Finance Bristol-Myers Squibb (BMY) Q4 2020 Earnings Call Transcript  Motley Fool Can Gilead Beat Bristol Myers Squibb With Its Cancer CAR-T Therapy?  The Motley Fool CLAIMSFILER ALERTS BRISTOL MYERS Investors to Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY  PRNewswire Bristol-Myers Squibb completes $20M investment in Compugen  Seeking Alpha Bristol Myers faces securities class action complaint  Seeking Alpha Bristol Myers Squibb to Report Results for Second Quarter 2021 on July 28, 2021  Business Wire Why Bristol Myers Stock Offers More Than Just A 3.44% Dividend Yield  Seeking Alpha Bristol Myers Squibb?s Breyanzi (lisocabtagene maraleucel) Significantly Improves Outcomes, Showing Superiority Over 20-Year Standard of Care in Second-Line Relapsed or Refractory Large B-cell Lymphoma Based on TRANSFORM Study Results  Yahoo Finance Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate  Reuters Why Bristol Myers Squibb Is A Top Socially Responsible Dividend Stock  Forbes Bristol Myers Gets Europe OK for Zeposia in Ulcerative Colitis >BMY  MarketWatch BRISTOL MYERS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Bristol-Myers Squibb Company - BMY  Yahoo Finance Bristol Myers Squibb Reports First Quarter Financial Results for 2021  Business Wire Bristol Myers drug wins first U.S. approval for Graft versus Host Disease prevention  Reuters Bristol Myers Squibb Stock Can Offer Better Returns Over Eli Lilly  Forbes Bristol Myers Squibb Provides Update on Status of Contingent Value Rights  Business Wire NVO: 4 Drug Manufacturing Stocks to Add to Your Dividend Portfolio in January Bristol Myers Squibb: Out Of The Rut  Seeking Alpha Bristol-Myers Squibb Company (BMY) Company Profile, News, Rankings | Fortune  Fortune Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers Squibb  BioSpace BRISTOL MYERS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers  Yahoo Finance Bristol-Myers Squibb (BMY) Files Mixed Shelf Registration Statement Analyst Expects Bristol to Settle Over $6 Billion Bet That Didn't Pay Out  Barron's Bristol Myers Squibb: A Classic Buffett Style 'Fat Pitch'  Seeking Alpha Bristol Myers Squibb (BMY) Stock Moves -1.61%: What You Should Know It had to happen: Ex-Celgene shareholders sue Bristol Myers Squibb for $6.4B in lost CVR cash, claiming 'blatant misconduct'  FiercePharma Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis  Business Wire Bristol-Myers Squibb becomes latest pharma to require employee vaccinations  Seeking Alpha Stock Market Tries To Rebound As Oil Industry's First Earnings Report Comes In Mixed  Investor's Business Daily Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term  Yahoo Finance Bristol Myers is sued for refusing COVID-19 vaccine religious exemptions  Reuters Bristol-Myers Squibb: Undervalued Dividend Contender, Offering Income, Dividend Growth, And Capital Appreciation  Seeking Alpha Bristol Myers Squibb and Five Leading Historically Black Colleges and Universities Launch Tomorrow's Innovators to Create Custom Biopharma Educational Programming and Increase Recruitment of Black Talent in the Biopharma Industry  Business Wire Bristol Myers 24 Hour Deadline Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits against Bristol-Myers Squibb Company - BMY  Yahoo Finance European Medicines Agency Validates Bristol Myers Squibb's Application for Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy  Business Wire Bolt Biotherapeutics Announces Clinical Collaboration with Bristol Myers Squibb to Study BDC-1001 in Combination with OpdivoŽ for Treatment of HER2-Expressing Solid Tumors  Yahoo Finance New Bristol Myers immunotherapy combo better than Opdivo alone in melanoma study  Reuters
For more news about Bristol-Myers Squ click here:
Bristol-Myers Squ News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources